Heartseed219A東証グロース医薬品FY ending Oct 2024, non-consolidated, J-GAAP
It lost about ¥119 for every ¥100 of sales at the operating level. Revenue changed +153.4% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2023 | — | —× | -25.8% | —× | — |
| 2024 | — | —× | -12.7% | —× | — |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Oct 2023 | FY ending Oct 2024 |
|---|---|---|
| Revenue | 345 | 874 |
| Cost of revenue | 0 | 0 |
| Gross profit | 345 | 874 |
| SG&A | 1,804 | 1,912 |
| Operating income | -1,460 | -1,039 |
| Pretax income | -1,457 | -819 |
| Income tax | 17 | -6 |
| Net income attributable to owners | -1,473 | -813 |
| Operating margin | -423.4% | -118.9% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Oct 2023 | FY ending Oct 2024 |
|---|---|---|
| Cash and equivalents | ¥4.59B | ¥5.3B |
| Total assets | ¥5.72B | ¥7.07B |
| Net assets | ¥5.27B | ¥6.62B |
| Share capital | ¥50M | ¥1.13B |
| Property, plant and equipment | ¥483.5M | ¥455.7M |
| Current assets | ¥5.03B | ¥6.4B |
| Current liabilities | ¥244.1M | ¥282.1M |
| Total liabilities | ¥450.2M | ¥444.3M |
| Equity attributable to owners of parent | ¥5.26B | ¥6.61B |
| Retained earnings | -¥2.96B | -¥2.77B |
EDINET (FSA Japan)
有価証券報告書－第9期(2023/11/01－2024/10/31)
Extracted from XBRL: 35 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.